A humble schoolteacher, Dattatreya Ramchandra Kaprekar, discovered the remarkable 6174 constant through simple number ...

ByteDance's drug unit showed an AI-designed IL-17 inhibitor at a Boston conference. The molecule targets interactions pharma called undruggable. Only trials will tell.

From designing algorithms to analyzing their efficiency, understanding these core concepts is key to solving problems in ...

Digital transformation has created vast new opportunities. But that didn’t mean getting rid of everything we already had.

In times when knowledge is stored and remixed as data, the tradition of storytelling still holds its own. The use of ...

In the late 1990s, search engines struggled with low-quality information. Larry Page and Sergey Brin developed a new approach ...

Joining us today is Panna Sharma, Chief Executive Officer, President and Director of Lantern Pharma, who will guide us through the demonstration and discuss the broader implications of this technology ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Michael Schmidt, CFA, is a staff member of FINRA's Dispute Resolution Board with 20+ years of experience in the financial market. Doretha Clemons, Ph.D., MBA, PMP, has been a corporate IT executive ...